1. Home
  2. ZSQR vs DNA Comparison

ZSQR vs DNA Comparison

Compare ZSQR & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Z Squared Inc. Common Stock

ZSQR

Z Squared Inc. Common Stock

N/A

Current Price

$7.83

Market Cap

697.4M

Sector

Finance

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.25

Market Cap

599.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZSQR
DNA
Founded
N/A
2008
Country
United States
United States
Employees
N/A
485
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.4M
599.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ZSQR
DNA
Price
$7.83
$9.25
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
992.3K
1.1M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.94
$5.37
52 Week High
$16.62
$17.58

Technical Indicators

Market Signals
Indicator
ZSQR
DNA
Relative Strength Index (RSI) 21.61 49.70
Support Level N/A $7.59
Resistance Level N/A $10.05
Average True Range (ATR) 1.76 0.84
MACD -0.60 -0.06
Stochastic Oscillator 7.23 20.97

Price Performance

Historical Comparison
ZSQR
DNA

About ZSQR Z Squared Inc. Common Stock

Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: